SURVIVAL IN ADULTS UNDERGOING KIDNEY TRANSPLANT FROM CADAVERIC DONORS COMPARED WITH PATIENTS ON WAITING LIST IN ARGENTINA 2005-2009 Bisigniano, Liliana.

Slides:



Advertisements
Similar presentations
The analysis of survival data in nephrology. Basic concepts and methods of Cox regression Paul C. van Dijk 1-2, Kitty J. Jager 1, Aeilko H. Zwinderman.
Advertisements

Survival Analysis. Key variable = time until some event time from treatment to death time for a fracture to heal time from surgery to relapse.
X Treatment population Control population 0 Examples: Drug vs. Placebo, Drugs vs. Surgery, New Tx vs. Standard Tx Let X = decrease (–) in cholesterol.
Survival Analysis-1 In Survival Analysis the outcome of interest is time to an event In Survival Analysis the outcome of interest is time to an event The.
Survival Analysis. Statistical methods for analyzing longitudinal data on the occurrence of events. Events may include death, injury, onset of illness,
the Cox proportional hazards model (Cox Regression Model)
Mugendi AG, BPharm, MPharm (Clin Pharm). Comparison of the effects of losartan and enalapril on renal function in adults with chronic kidney disease at.
Liver fibrosis regression after anti HCV therapy and the rate of death, liver-related death, liver- related complications, and hospital.
On ranking in survival analysis: Bounds on the concordance index
PAIRED EXCHANGE KIDNEY TRANSPLANTATION EXPERIENCE OF TURKEY Levent Yucetin MD. Antalya Medicalpark Healthcare Group Transplant Center Senior Transplant.
INFLUENCE OF HLA MISMATCH ON GRAFT SURVIVAL IN RENAL TRASPLANTATION IN ADULTS IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi.
Why don’t indigenous dialysis patients receive transplants – waitlist or allocation? N. Khanal 1, P. Clayton 1, S. McDonald 1, M. Jose 2 1 The University.
PATIENT-GRAFT SURVIVAL ANALYSIS IN KIDNEY TRASPLANT WITH DECEASED DONOR IN CHILDREN IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo.
Fioretti S.; Antik A; Busto S; Bacque MC; Schiavelli R; Domenech A; Vallejos A. Analysis of Kidneys Procured by the Transplant Institute and DGF in Transplant.
Survival Analysis approach in evaluating the efficacy of ARV treatment in HIV patients at the Dr GM Hospital in Tshwane, GP of S. Africa Marcus Motshwane.
DONOR RISK INDEX-LIVER GRAFT SURVIVAL ASSOCIATION IN PATIENTS OVER 18 YEARS OF AGE IN ARGENTINA Bisigniano Liliana MD., López-Rivera Arturo MD., Tagliafichi.
Quebec experience from 2003 to 2009 M Carrier MD, JF Lize MD and Quebec transplant programs Impact of Expanded Criteria Donors on outcomes of recipients.
R.Ibar, C.Soratti, M.Torres. A Quality Assurance Program in the procurement process that includes the monitoring of neurocritical patients with GCS ≤7.
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
소화기내과 김경엽 Gastroenterology 2011;140:
Kidney Graft Survival Rates do not improve by era: the impact of factor “Age” E. Bertoni MD, A. Larti MD, G. Rosso MD and M. Salvadori MD Renal Unit –
Carolinas Medical Center, Charlotte, NC Website:
Organ Donation The gift of Life.
Stephen P. McDonald, Graeme R. Russ  Kidney International 
ANZDATA Epidemiology Fellow
Kidney Transplantation and Wait-Listing Rates from the International Dialysis Outcomes and Practice Patterns Study (DOPPS)
UK Renal Registry 10th Annual Report 2007
The Clinical Significance of Uric Acid and Complement Activation in the Progression of IgA Nephropathy Kidney Blood Press Res 2016;41: DOI: /
John P. Dickerson, Tuomas Sandholm In AAAI, 2015
UK Renal Registry 15th Annual Report
Number of transplants, by donor type figure 8.1
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
Clinical outcome after SVR: Veterans Affairs
Volume 66, Issue 1, Pages (July 2004)
Liver only transplants in the UK Question 2: In terms of survival benefit.
HEART-LUNG TRANSPLANTATION
HEART TRANSPLANTATION
Renal function and outcome after heart transplantation
HEART TRANSPLANTATION
Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL.
Risk factors in deceased-donor transplants Risk factor 1988
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2010
Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes  Eduardo Lacson, MD, MPH, Weiling Wang,
Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II
Patient and Graft Survival Following Kidney Transplantation in Recipients With Cystinosis: A Cohort Study  Rebecca A. Spicer, MBChB, Philip A. Clayton,
UK Renal Registry 13th Annual Report
HEART-LUNG TRANSPLANTATION
HEART-LUNG TRANSPLANTATION
Impact of Hepatitis C, HIV, or Both on Survival in Veterans in Care Before and After the Introduction of HAART (1996) SL Fultz, MD, MPH CH Chang, PhD AA.
Physical Activity Dose for Hemodialysis Patients: Where to Begin
Risk factor Treatment GFR at baseline GFR at 5 years p Cadaveric donor
Survival by time of day of hemodialysis: analysis of United States renal data system dialysis morbidity and mortality waves III/IV  Kevin C Abbott, MD,
HEART-LUNG TRANSPLANTATION
Kaplan-Meier survival curves for the development of diabetes by quartiles of baseline pedometer steps. Kaplan-Meier survival curves for the development.
Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD 
Stephen P. McDonald, Graeme R. Russ  Kidney International 
JAMA Internal Medicine 2018;178(11):
Stephen P. Mcdonald, Graeme R. Russ  Kidney International 
Volume 71, Issue 12, Pages (June 2007)
A: Kaplan-Meier curves depicting the cumulative probability of CVE in patients with low (
Volume 83, Issue 3, Pages (March 2013)
Volume 87, Issue 3, Pages (March 2015)
Increased Mortality at Low-Volume Orthotopic Heart Transplantation Centers: Should Current Standards Change?  Eric S. Weiss, MD, Robert A. Meguid, MD,
The Impact of Acute Renal Failure on Early and Late Outcomes After Thoracic Aortic Endovascular Repair  Joseph D. Drews, BS, Himanshu J. Patel, MD, David.
Kaplan-Meier estimated kidney graft and patient survival among patients with type 2 diabetes mellitus (T2DM), age 18–59 years, body mass index < 30 kg/m2.
Kaplan-Meier survival curves and the log rank test
(A). (A). Kaplan-Meier plot of event-free survival in 27 LMNA mutation carriers and 78 DCM control patients. Death, heart transplantation, resuscitation.
HEART-LUNG TRANSPLANTATION
Presentation transcript:

SURVIVAL IN ADULTS UNDERGOING KIDNEY TRANSPLANT FROM CADAVERIC DONORS COMPARED WITH PATIENTS ON WAITING LIST IN ARGENTINA Bisigniano, Liliana MD., López-Rivera Arturo MD., Tagliafichi Viviana, Fernández Víctor MD., Soratti Carlos MD.

Introduction In population-based studies, renal transplantation has been shown to improve survival compared to dialysis patients awaiting transplantation

Objective To evaluate the association between renal transplantation using cadaveric donors and patient survival compared with patients on waiting list in Argentina, considering patients over the age of 18.

Materials & Methods The information was obtained from SINTRA for the period January 2005 to June The follow-up period was closed in December Survival time was defined as the time between inclusion in waiting list till death, the term of the study (June 2009), or the last follow-up visit recorded, what occurred first in time.

Materials & Methods  The Kaplan Meir method was used, and survival was measured at 30 days, 1 and 5 years.  The Log Rank test was used to compare the curves and their statistical significance.  With Cox regression with a time –dependant covariable, we analysed the survival of patients with the same 0 time on listing.  Risk was measured during the total observation period, at 30 days, 1 year and > 1 year.

Results TRASPLANTEDWAITING LIST SAMPLE AGE years years

Results Chi p= < TrasplantedWaiting list 30 days99.8%99.7% 1 year96.2%94.6% 5 year79.9%66.6%

Results Cox time dependent regression HRCI95%p= 1.40% <0.0001

Results COX TIME DEPENDENT REGRESSION IN DIFERENT COHORT TIME HRCIp= 30 days < year < > 1 year <0.0001

Conclusions Survival, both at baseline and in the long term, is better in transplant patients as compared to patients on waiting list. In Cox time–dependant regression the risk of death during the first 30 days is 4 times higher in transplant patients. This reverses and at 1 year, transplant patients are 60% less likely to die, and after one year this probability is 81% lower (p=<0.0001).

Take Home Message This confirms the need to foster the donation and procurement of organs for transplantation.

Thank you for your attention